References
Jaguszewski M, Ghadri JR, Zipponi M, Bataiosu DR, Diekmann J, Geyer V, Neumann CA, Huber MA, Hagl C, Erne P, Luscher TF, Templin C (2015) Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios. Clin Res Cardiol 104(2):124–135. doi:10.1007/s00392-014-0757-4
Schinke K, Langwieser N, Laugwitz KL, Ibrahim T (2015) A potential life-threatening complication after implantation of a bioresorbable scaffold for coronary stenting within a mechanically stressed region. Clin Res Cardiol 104(4):366–367. doi:10.1007/s00392-014-0808-x
Gil RJ, Bil J, Pawlowski T, Yuldashev N, Kolakowski L, Janczak J, Jablonski W, Palinski P (2016) The use of bioresorbable vascular scaffold Absorb BVS(R) in patients with stable coronary artery disease: one-year results with special focus on the hybrid bioresorbable vascular scaffolds and drug eluting stents treatment. Kardiol Pol 74(7):627–633. doi:10.5603/KP.a2015.0250
Trobs M, Achenbach S, Rother J, Klinghammer L, Schlundt C (2016) Bioresorbable vascular scaffold thrombosis in a consecutive cohort of 550 patients. Catheter Cardiovasc Interv. doi:10.1002/ccd.26569
Raber L, Brugaletta S, Yamaji K, O’Sullivan CJ, Otsuki S, Koppara T, Taniwaki M, Onuma Y, Freixa X, Eberli FR, Serruys PW, Joner M, Sabate M, Windecker S (2015) Very Late Scaffold Thrombosis: Intracoronary Imaging and Histopathological and Spectroscopic Findings. J Am Coll Cardiol 66(17):1901–1914. doi:10.1016/j.jacc.2015.08.853
Braun D, Baquet M, Massberg S, Mehilli J, Hausleiter J (2016) Collapse of a Bioresorbable Novolimus-Eluting Coronary Scaffold. JACC Cardiovasc Interv 9 (1):e13–14. doi:10.1016/j.jcin.2015.10.019
Serruys PW, Chevalier B, Sotomi Y, Cequier A, Carrie D, Piek JJ, Van Boven AJ, Dominici M, Dudek D, McClean D, Helqvist S, Haude M, Reith S, de Sousa Almeida M, Campo G, Iniguez A, Sabate M, Windecker S, Onuma Y (2016) Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial. Lancet 388(10059):2479–2491. doi:10.1016/S0140-6736(16)32050-5
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states the following conflicts of interest: C.S. is principal investigator within the DEsolve I trial (NCT02086006); V.S.S., U.L., M.R., Y.S.A. and D.M.L. have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Schneider, V.S., Skurk, C., Riedel, M. et al. Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent. Clin Res Cardiol 106, 557–559 (2017). https://doi.org/10.1007/s00392-017-1091-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-017-1091-4